Dr. Robert Lowsky, MD
Claim this profileStanford University
Studies Acute Lymphoblastic Leukemia
Studies Lymphoblastic Leukemia-Lymphoma
12 reported clinical trials
20 drugs studied
Area of expertise
1Acute Lymphoblastic Leukemia
CD19 positive
Philadelphia Chromosome positive
CD22 positive
2Lymphoblastic Leukemia-Lymphoma
CD19 positive
CD22 negative
CD19 negative
Affiliated Hospitals
Clinical Trials Robert Lowsky, MD is currently running
Axicabtagene Ciloleucel
for Non-Hodgkin Lymphoma
This is a phase Ib study to establish safety of Axi-Cel-2 in patients with Large B Cell Lymphoma (LBCL) who are at high risk of relapse.
Recruiting1 award Phase 1
CAR T-Cell Therapy
for Leukemia
This trial is testing a treatment that uses special immune cells from a donor, modified to target and kill cancer cells, in adults with a specific type of blood cancer. These cells act like guided missiles, finding and destroying cancer cells by recognizing specific markers.
Recruiting1 award Phase 1
More about Robert Lowsky, MD
Clinical Trial Related1 year of experience running clinical trials · Led 12 trials as a Principal Investigator · 6 Active Clinical TrialsTreatments Robert Lowsky, MD has experience with
- Cyclophosphamide
- Donor Regulatory T Cells
- Immune Tolerance After Kidney Transplant
- Donor Blood Stem Cells And T Cells
- Hematopoietic Cell Transplantation
- Total Lymphoid Irradiation
Breakdown of trials Robert Lowsky, MD has run
Acute Lymphoblastic Leukemia
Lymphoblastic Leukemia-Lymphoma
Non-Hodgkin's Lymphoma
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Robert Lowsky, MD specialize in?
Robert Lowsky, MD focuses on Acute Lymphoblastic Leukemia and Lymphoblastic Leukemia-Lymphoma. In particular, much of their work with Acute Lymphoblastic Leukemia has involved CD19 positive patients, or patients who are Philadelphia Chromosome positive.
Is Robert Lowsky, MD currently recruiting for clinical trials?
Yes, Robert Lowsky, MD is currently recruiting for 6 clinical trials in Palo Alto California. If you're interested in participating, you should apply.
Are there any treatments that Robert Lowsky, MD has studied deeply?
Yes, Robert Lowsky, MD has studied treatments such as Cyclophosphamide, Donor Regulatory T Cells, Immune tolerance after kidney transplant.
What is the best way to schedule an appointment with Robert Lowsky, MD?
Apply for one of the trials that Robert Lowsky, MD is conducting.
What is the office address of Robert Lowsky, MD?
The office of Robert Lowsky, MD is located at: Stanford University, Palo Alto, California 94305 United States. This is the address for their practice at the Stanford University.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.